Tag Articles

Standing committee raps government for inaction against harmful drugs

April 27, 2013
A new parliamentary standing committee report sheds light on the government’s ‘dilly-dallying and procrastination’ over serious irregularities in the approval of various drugs, many of them banned in countries like the US. …

WHO okays India’s vaccine regulatory system

April 10, 2013
The Indian vaccine regulatory system has met the standards set by the World Health Organisation (WHO), health ministry officials said  on Tuesday. A WHO-led team of international experts reviewed the National Regulatory …

‘436 died during clinical trials last year’

February 24, 2013
As many as 436 people died last year due to serious adverse events (SAE) during clinical trials and the Union Health Minister has said the deaths could be due to life-threatening diseases such as cancer, heart failure and stroke …

Can ethical committees stop illegal clinical trials?

February 15, 2013
In a move to discourage the rampant frequency with which untested drugs are released in India, all pharmaceutical companies that conduct clinical trials will have to register internal ethics committees. The latest gazette …

India’s drug control body’s hall of shame

January 30, 2013
14 years – that’s how long Deanxit, anti-depressant marketed by a Danish company was sold in this country until its safety and efficacy was questioned. The drug in question is an antidepressant which is mostly marketed in …

Did pharmaceutical companies carry out illegal drug trials on tribal girls?

January 8, 2013
The SC on Monday admitted a PIL alleging that certain pharma companies had conducted illegal drug tests of a cervical cancer vaccine on tribal girls. The petition alleges that big pharma companies including Glaxo Smithkline and …

You’re treating patients like guinea pigs: Supreme Court

January 4, 2013
The SC on Thursday pointed out the government's failure to halt unethical clinical trials by multinational drug companies on Indian patients who were used as ‘guinea pigs’. Referring to a May 2012 report of the Parliamentary …

India’s vaccine regulatory body gets WHO team’s stamp of approval

December 18, 2012
A WHO team today gave a green light to India’s vaccine regulatory system for maintaining high international standards. India`s Rs 19,000-crore vaccine industry accounts for exports worth 13 billion US dollars to 150 countries …

Illegal drug approvals by CDSCO to be examined by govt: Azad

December 12, 2012
Union Health Minister Ghulam Nabi Azad said that the report of an expert committee set up to examine the issue of alleged approval of drugs without clinical trial by Central Drugs Standard Control Organisation (CDSCO) is being …

Govt working on methods to curb spurious drugs: Health Ministry

September 12, 2012
The centre is working on improved technology to detect spurious drugs, according to joint secretary in the ministry Arun Panda. "The Health Ministry is keen on building its capacities across the country...It is also working on …

12th Five Year Plan to focus on drug regulation

September 11, 2012
India is working to strengthen policies related to drug regulation in order to check spurious drugs in the market, Minister of State for Health Sudip Bandyopadhyay said. Speaking at a two-day international workshop here on …

Clinical trial victims from 2011 get only Rs 2.2 lakh compensation!

September 8, 2012
If you had Rs 2.2 lakh to spare, what would you do with it? Could it replace a person in your life? Atleast the Government seems to think it can! It is indeed alarming that the value of a life is so cheap is India. And what's …

CDSCO looks to crackdown on illegal drug sales

September 5, 2012
In a bid to crack down on illegal commercial sale of drugs the CDSCO has written to all state and zonal drug inspectors to conduct surprise inspections across the six lakh chemist shops scattered around the country. These drugs …

Pharma companies must submit safety records every 6 months

September 4, 2012
The Drug Controller General of India (DCGI) has asked all pharmaceutical companies to submit safety details of their new drugs every six months after their launch, failing which their licenses would be cancelled. They’re …